Aligos Therapeutics Inc banner

Aligos Therapeutics Inc
F:5WK0

Watchlist Manager
Aligos Therapeutics Inc Logo
Aligos Therapeutics Inc
F:5WK0
Watchlist
Price: 5.33 EUR -1.48% Market Closed
Market Cap: €32.8m

Wall St Price Targets

5WK0 Price Targets Summary
Aligos Therapeutics Inc

Wall Street analysts forecast 5WK0 stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for 5WK0 is 36.36 EUR with a low forecast of 18.7 EUR and a high forecast of 48.61 EUR.

Lowest Forecast
Price Target
18.7 EUR
251% Upside
Average Forecast
Price Target
36.36 EUR
582% Upside
Highest Forecast
Price Target
48.61 EUR
812% Upside
Aligos Therapeutics Inc Competitors:
Price Targets
UFPT
UFP Technologies Inc
50% Upside
FBIZ
First Business Financial Services Inc
19% Upside
ACAD
ACADIA Pharmaceuticals Inc
43% Upside
NN
NextNav Inc
41% Upside
VNOM
Viper Energy Partners LP
22% Upside
SUPN
Supernus Pharmaceuticals Inc
22% Upside

Revenue
Forecast

N/A
Past Growth
118% / Year
Estimated Growth
Estimates Accuracy
6%
Average Beat
N/A
Past Growth
118% / Year
Estimated Growth
Estimates Accuracy
6%
Average Beat

The compound annual growth rate for Revenue over the next 8 years is 118%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Miss

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-69%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-69%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is 5WK0's stock price target?
Price Target
36.36 EUR

According to Wall Street analysts, the average 1-year price target for 5WK0 is 36.36 EUR with a low forecast of 18.7 EUR and a high forecast of 48.61 EUR.

What is the Revenue forecast for Aligos Therapeutics Inc?
Projected CAGR
118%

The compound annual growth rate for Revenue over the next 8 years is 118%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett